Strengthening Families & Communities LLC’s Alnylam Pharmaceuticals ALNY Stock Holding History

Strengthening Families & Communities LLC’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$903	Buy	+3	New	+$905	﹤0.01%	672

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Strengthening Families & Communities LLC's ALNY Position: Q2 2026 in Review

Strengthening Families & Communities LLC opened a new position in Alnylam Pharmaceuticals (ALNY) in Q2 2026: 3 shares worth $903. The stake represents ﹤0.01% of the portfolio and ranks #672 among its holdings.

784 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

Strengthening Families & Communities LLC held 3 shares of Alnylam Pharmaceuticals worth $903 as of Q2 2026.
Alnylam Pharmaceuticals was a new Strengthening Families & Communities LLC position in Q2 2026.
Alnylam Pharmaceuticals made up ﹤0.01% of Strengthening Families & Communities LLC's portfolio in Q2 2026, its #672 holding.
784 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Strengthening Families & Communities LLC's 13F filing for Q2 2026, filed 11 Aug 2026.